ArticleJournal of thrombosis and thrombolysis2022

Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement.

Zain M Virk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.